Validation of the Global Resource of Eczema Trials (GREAT Database)

Overview

Journal BMC Dermatol

Publisher Biomed Central

Specialty Dermatology

Date 2015 Apr 19

PMID 25887502

Citations 5

Authors

Helen Nankervis

Alison Devine

Hywel C Williams

John R Ingram

Elizabeth Doney

Finola Delamere

Sherie Smith

Kim S Thomas

Affiliations

Soon will be listed here.

Abstract

Background: Eczema (syn. Atopic Eczema or Atopic Dermatitis) is a chronic, relapsing, itchy skin condition which probably results from a combination of genetic and environmental factors. The Global Resource of EczemA Trials (GREAT) is a collection of records of randomised controlled trials (RCTs) for eczema treatment produced from a highly sensitive search of six reference databases. We sought to assess the sensitivity of the GREAT database as a tool to save future researchers repeating extensive bibliographic searches.

Methods: All Cochrane systematic review on treatments for eczema and five non-Cochrane systematic reviews on eczema were identified as a reference set to assess the utility of the GREAT database in identifying randomised controlled trials (RCTs). RCTs included in the systematic reviews were checked for inclusion in the GREAT database by two independent authors. A third author resolved any disagreements.

Results: Five Cochrane and six non-Cochrane systematic reviews containing a total of 105 RCTs of eczema treatments were included. Of these, 95 fitted the inclusion criteria for the GREAT database and 88 were published from 2000 onwards. Of the 88 eligible studies, 92% were found in the GREAT database. Seven trials were not included in the GREAT database - two of these were reported within a review paper and one as an abstract with no trial results.

Conclusions: The sensitivity of the GREAT database for trials from 2000 onwards was high (75/88 trials, 94%). Sensitivity for the period prior to 2000 was less sensitive, due to differences in how the trials were identified prior to this time. 'Dual' filtering for new records has recently become part of the GREAT database methodology and should further improve the sensitivity of the database in time. The GREAT database can be considered as a primary source for future systematic reviews including randomised controlled trials of eczema treatments, but searches should be supplemented by checking reference lists for eligible trials, searching trial registries and contacting pharmaceutical companies for unpublished studies.

Citing Articles

[Health care of chronic inflammatory skin diseases : Do affected individuals seek dermatological care?].

Schielein M, Tizek L, Seifert F, Biedermann T, Zink A Hautarzt. 2019; 70(11):875-882.

PMID: 31560083 DOI: 10.1007/s00105-019-04481-6.

Knowledge mobilisation: an ethnographic study of the influence of practitioner mindlines on atopic eczema self-management in primary care in the UK.

Cowdell F BMJ Open. 2019; 9(7):e025220.

PMID: 31350238 PMC: 6661925. DOI: 10.1136/bmjopen-2018-025220.

Clinical Research Informatics: Supporting the Research Study Lifecycle.

Johnson S Yearb Med Inform. 2017; 26(1):193-200.

PMID: 29063565 PMC: 6239240. DOI: 10.15265/IY-2017-022.

A systematic review of pediatric clinical trials of high dose vitamin D.

Nama N, Menon K, Iliriani K, Pojsupap S, Sampson M, OHearn K PeerJ. 2016; 4:e1701.

PMID: 26966655 PMC: 4782742. DOI: 10.7717/peerj.1701.

A multi-centre, parallel group superiority trial of silk therapeutic clothing compared to standard care for the management of eczema in children (CLOTHES Trial): study protocol for a randomised controlled trial.

Harrison E, Haines R, Cowdell F, Sach T, Dean T, Pollock I Trials. 2015; 16:390.

PMID: 26329718 PMC: 4557840. DOI: 10.1186/s13063-015-0921-9.

References

Hung S, Lin Y, Chu C, Lee C, Liang T, Yang Y . Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007; 98(1):51-6. DOI: 10.1016/S1081-1206(10)60859-9. View

Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C . Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2010; 164(2):415-28. DOI: 10.1111/j.1365-2133.2010.10030.x. View

Nankervis H, Maplethorpe A, Williams H . Mapping randomized controlled trials of treatments for eczema--the GREAT database (the Global Resource of EczemA Trials: a collection of key data on randomized controlled trials of treatments for eczema from 2000 to 2010). BMC Dermatol. 2011; 11:10. PMC: 3125320. DOI: 10.1186/1471-5945-11-10. View

Ersser S, Latter S, Sibley A, Satherley P, Welbourne S . Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2007; (3):CD004054. DOI: 10.1002/14651858.CD004054.pub2. View

Yin Z, Xu J, Luo D . Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis. J Biomed Res. 2013; 25(6):385-91. PMC: 3596717. DOI: 10.1016/S1674-8301(11)60051-1. View

Zhang W, Leonard T, Bath-Hextall F, Chambers C, Lee C, Humphreys R . Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev. 2005; (2):CD002291. DOI: 10.1002/14651858.CD002291.pub3. View

Siegfried E, Korman N, Molina C, Kianifard F, Abrams K . Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. J Dermatolog Treat. 2006; 17(3):143-50. DOI: 10.1080/09546630600647297. View

Boyle R, Bath-Hextall F, Leonardi-Bee J, Murrell D, Tang M . Probiotics for treating eczema. Cochrane Database Syst Rev. 2008; (4):CD006135. DOI: 10.1002/14651858.CD006135.pub2. View

Ashcroft D, Chen L, Garside R, Stein K, Williams H . Topical pimecrolimus for eczema. Cochrane Database Syst Rev. 2007; (4):CD005500. PMC: 10043871. DOI: 10.1002/14651858.CD005500.pub2. View

10.

FATTAH A, Faris R, Tadros S . A comparative clinical evaluation of a new topical steroid 'halcinonide' and hydrocortisone in steroid-responsive dermatoses. J Int Med Res. 1976; 4(4):228-31. DOI: 10.1177/030006057600400403. View

11.

Hoare C, Li Wan Po A, Williams H . Systematic review of treatments for atopic eczema. Health Technol Assess. 2001; 4(37):1-191. PMC: 4782813. View

12.

Nakagawa H . Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. Clin Drug Investig. 2006; 26(5):235-46. DOI: 10.2165/00044011-200626050-00001. View

13.

POLANO M, de Vries H . Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid and neomycin containing ointments. Dermatologica. 1960; 120:191-9. DOI: 10.1159/000255315. View

14.

Leyden J, MARPLES R, Kligman A . Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974; 90(5):525-30. DOI: 10.1111/j.1365-2133.1974.tb06447.x. View

15.

Ravenscroft J, Layton A, Eady E, Murtagh M, Coates P, Walker M . Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol. 2003; 148(5):1010-7. DOI: 10.1046/j.1365-2133.2003.05292.x. View

16.

Birnie A, Bath-Hextall F, Ravenscroft J, Williams H . Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev. 2008; (3):CD003871. DOI: 10.1002/14651858.CD003871.pub2. View

17.

Nilsson E, Henning C, Magnusson J . Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992; 27(1):29-34. DOI: 10.1016/0190-9622(92)70151-5. View

18.

Larsen F, Simonsen L, Melgaard A, Wendicke K, Henriksen A . An efficient new formulation of fusidic acid and betamethasone 17-valerate (fucicort lipid cream) for treatment of clinically infected atopic dermatitis. Acta Derm Venereol. 2007; 87(1):62-8. DOI: 10.2340/00015555-0174. View

19.

Bath-Hextall F, Delamere F, Williams H . Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev. 2008; (1):CD005203. PMC: 6885041. DOI: 10.1002/14651858.CD005203.pub2. View

20.

Svensson A, Chambers C, Ganemo A, Mitchell S . A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis. Curr Med Res Opin. 2011; 27(7):1395-406. DOI: 10.1185/03007995.2011.582483. View